Influenza A virus vaccine H5N1 (Adimmune)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameInfluenza A virus vaccine H5N1 (Adimmune)
Drug Alias NamePandemic influenza virus vaccine H5N1甲型流感病毒H5N1疫苗 - AdimmuneAdjuvanted H5N1 influenza virus vaccine - AdimmuneAdimFlu-W
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAdimmune Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdimmune Corp
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A